Eyebot, a startup providing a 90-second imaginative and prescient check kiosk that delivers doctor-verified glasses prescriptions, has secured $20 million in Sequence A funding.
The Boston-based startup, based in 2021, streamlines how individuals entry imaginative and prescient care by eliminating conventional obstacles, comparable to appointment delays, restricted accessibility, complicated insurance coverage necessities, and value.
Its kiosks, already present in malls, universities, retail shops, pharmacies, grocery chains, colleges, and airports, ship a free, 90-second imaginative and prescient check. In line with the corporate, every check generates a prescription that’s then reviewed and authorised by licensed eye medical doctors, making certain quick, handy, and dependable prescriptions.
The brand new funding, which brings Eyebot’s whole funding to greater than $30 million, comes roughly a yr after the startup raised its seed round in June 2024. Since then, the startup has carried out greater than 45,000 free imaginative and prescient checks and is on observe to ship over half one million yearly, it says.
“Since our seed spherical, the shift has been dramatic. We’ve gone from piloting to partnering with a few of the largest firms within the U.S., launching kiosks all around the nation, and delivering tens of 1000’s of imaginative and prescient checks,” Matthias Hofmann, co-founder and CEO of Eyebot, informed TechCrunch. “Income is scaling and our staff has doubled in measurement. Most significantly, we’ve confirmed the mannequin works: persons are utilizing Eyebot, medical doctors are validating the outcomes, and retailers are excited in regards to the site visitors it drives.”
What units Eyebot aside, Hofmann mentioned, is its mixture of comfort and medical assurance. Each check is reviewed by a health care provider, and all prescriptions are issued below scientific supervision. If check outcomes point out something uncommon, sufferers are referred for in-person, complete exams. That stability of pace plus scientific oversight earns belief, he says.
“At our mall areas, we’ve seen shocking uptake from dad and mom with children,” Hofmann mentioned. “They’ll cease between shops, strive Eyebot — typically even whereas holding their children’ arms — and depart with a prescription in simply a few minutes.”
Techcrunch occasion
San Francisco
|
October 27-29, 2025
Convincing conventional eye care suppliers to embrace a tech-first method has confirmed troublesome. Early skepticism ran deep: medical doctors apprehensive about accuracy, whereas sufferers questioned whether or not a course of so quick may very well be dependable, in response to Hofmann. He says that hesitancy eased as soon as suppliers discovered that have medical doctors overview each consequence, many with greater than a decade of expertise.
Eyebot is within the early phases of commercialization. Its imaginative and prescient check is obtainable free to shoppers, and if a prescription is required, one of many firm’s medical doctors verifies it for a charge. Moreover, the corporate leases its kiosks to optical retailers, eyewear manufacturers, and impartial practices.
With the Sequence A, the corporate plans to scale kiosk deployment and develop its staff throughout product, scientific operations, and business progress, the CEO mentioned.
The newest spherical was led by Basic Catalyst and included participation from returning traders AlleyCorp, Baukunst, Village International, Humba Enterprise, Ravelin, and Ubiquity Ventures.
Trending Merchandise
